Literature DB >> 7726119

From coronary artery disease to heart failure: role of the hibernating myocardium.

S H Rahimtoola1.   

Abstract

Hibernating myocardium is defined as persistently impaired myocardial and left ventricular (LV) function at rest resulting from reduced myocardial blood flow. It may occur in unstable angina and chronic stable angina, acute myocardial infarction, and LV dysfunction and congestive heart failure. Recovery of the hibernating myocardium has clearly been shown to occur with the establishment of successful revascularization either by coronary bypass surgery or by percutaneous transluminal coronary angioplasty. It may be possible to show recovery of the viable myocardium by reducing myocardial oxygen demand and/or by increasing coronary blood flow with pharmaceutical agents.

Entities:  

Mesh：

Year:  1995        PMID： 7726119     DOI： 10.1016/s0002-9149(99)80443-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  11 in total

Review 1.  Single photon emission computed tomography perfusion imaging for assessment of myocardial viability and management of heart failure.

Authors:  Steven Burrell; Sharmila Dorbala; Marcelo F Di Carli
Journal:  Curr Cardiol Rep       Date:  2003-01       Impact factor: 2.931

2.  Human myocardial ATP content and in vivo contractile function.

Authors:  R C Starling; D F Hammer; R A Altschuld
Journal:  Mol Cell Biochem       Date:  1998-03       Impact factor: 3.396

3.  Pulsed wave tissue Doppler imaging for the quantification of contractile reserve in stunned, hibernating, and scarred myocardium.

Authors:  M Bountioukos; A F L Schinkel; J J Bax; V Rizzello; R Valkema; B J Krenning; E Biagini; E C Vourvouri; J R T C Roelandt; D Poldermans
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

4.  Dedifferentiated cardiomyocytes from chronic hibernating myocardium are ischemia-tolerant.

Authors:  J Ausma; F Thoné; G D Dispersyn; W Flameng; J L Vanoverschelde; F C Ramaekers; M Borgers
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

5.  Amlodipine in ischaemic left ventricular dysfunction with mild to moderate heart failure.

Authors:  G P Perna; G Valle; N Cianfrone; G D Luca; C Amico; C Coli
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

Review 6.  Acquisition, Processing, and Interpretation of PET 18F-FDG Viability and Inflammation Studies.

Authors:  Emel Celiker-Guler; Terrence D Ruddy; R Glenn Wells
Journal:  Curr Cardiol Rep       Date:  2021-07-16       Impact factor: 2.931

Review 7.  Neovascularization derived from cell transplantation in ischemic myocardium.

Authors:  Denis Angoulvant; Shafie Fazel; Ren-Ke Li
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

8.  Tachycardia-induced Cardiomyopathy (Tachycardiomyopathy).

Authors:  Hassan A Mohamed
Journal:  Libyan J Med       Date:  2007-03-01       Impact factor: 1.657

9.  Relation between regional and global systolic function in patients with ischemic cardiomyopathy after beta-blocker therapy or revascularization.

Authors:  T A M Kaandorp; J J Bax; S E Bleeker; J Doornbos; E P Viergever; D Poldermans; E E van der Wall; A de Roos; H J Lamb
Journal:  J Cardiovasc Magn Reson       Date:  2010-01-27       Impact factor: 5.364

10.  Reperfusion normalizes motor activation patterns in large-vessel disease.

Authors:  Mohamad Chmayssani; Ronald M Lazar; Joy Hirsch; Randolph S Marshall
Journal:  Ann Neurol       Date:  2009-02       Impact factor: 10.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.